Update shared on 03 Nov 2025
Fair value Increased 0.90%Analysts have raised their price target for IHH Healthcare Berhad slightly, from RM8.45 to RM8.52. This reflects modest adjustments in their fair value assessments and expectations for profitability.
What's in the News
- IHH Healthcare Berhad has announced an interim single tier cash dividend of RMB 0.050 per ordinary share for the financial year ending 31 December 2025 (Key Developments).
- The ex-dividend date is set for 29 September 2025, with the entitlement date on 30 September 2025 (Key Developments).
- Dividend payments are scheduled for 30 October 2025 (Key Developments).
Valuation Changes
- The Fair Value Estimate has risen slightly, increasing from MYR 8.45 to MYR 8.52 per share.
- The Discount Rate remains unchanged at 8.45%.
- The Revenue Growth projection has declined marginally from 9.02% to 8.98%.
- The Net Profit Margin has edged up slightly, moving from 8.26% to 8.27%.
- The Future P/E Ratio has increased modestly from 35.99x to 36.36x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.